207 related articles for article (PubMed ID: 26782446)
1. Clinical significance of serum miR-196a in cervical intraepithelial neoplasia and cervical cancer.
Liu P; Xin F; Ma CF
Genet Mol Res; 2015 Dec; 14(4):17995-8002. PubMed ID: 26782446
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of Serum hsa-mir-92a in Patients with Cervical Cancer.
Kong Q; Tang Z; Xiang F; Jiang J; Yue H; Wu R; Kang X
Clin Lab; 2017 Feb; 63(2):335-340. PubMed ID: 28182350
[TBL] [Abstract][Full Text] [Related]
3. A circulating serum miRNA panel as early detection biomarkers of cervical intraepithelial neoplasia.
Xin F; Liu P; Ma CF
Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4846-4851. PubMed ID: 27981553
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood circulating microRNA-4636/-143 for the prognosis of cervical cancer.
Yin S; Yang M; Li X; Zhang K; Tian J; Luo C; Bai R; Lu Y; Wang M
J Cell Biochem; 2020 Jan; 121(1):596-608. PubMed ID: 31407404
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA Biomarkers of High-Grade Cervical Intraepithelial Neoplasia in Liquid Biopsy.
Causin RL; da Silva LS; Evangelista AF; Leal LF; Souza KCB; Pessôa-Pereira D; Matsushita GM; Reis RM; Fregnani JHTG; Marques MMC
Biomed Res Int; 2021; 2021():6650966. PubMed ID: 33954190
[TBL] [Abstract][Full Text] [Related]
6. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
7. Association study of relationships of polymorphisms in the miR-21, miR-26b, miR-221/222 and miR-126 genes with cervical intraepithelial neoplasia and cervical cancer.
Yang J; Yan Z; Wang Y; Xu J; Li R; Li C; Liu S; Shi L; Yao Y
BMC Cancer; 2021 Sep; 21(1):997. PubMed ID: 34488676
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of microRNA-196a predicts poor prognosis in human ovarian carcinoma.
Fan Y; Fan J; Huang L; Ye M; Huang Z; Wang Y; Li Q; Huang J
Int J Clin Exp Pathol; 2015; 8(4):4132-7. PubMed ID: 26097603
[TBL] [Abstract][Full Text] [Related]
9. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
[TBL] [Abstract][Full Text] [Related]
10. Serum CCAT2 as a biomarker for adjuvant diagnosis and prognostic prediction of cervical cancer.
Cao X; Yao J; Jia M; Shen X; Zhang J; Ju S
J Ovarian Res; 2022 Feb; 15(1):20. PubMed ID: 35115025
[TBL] [Abstract][Full Text] [Related]
11. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
12. Circulating and tissue miR-100 acts as a potential diagnostic biomarker for cervical cancer.
Yamanaka Z; Sasaki T; Yamanaka A; Kato K; Nishi H
Cancer Biomark; 2021; 32(4):551-558. PubMed ID: 34334379
[TBL] [Abstract][Full Text] [Related]
13. Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors.
Zheng M; Hou L; Ma Y; Zhou L; Wang F; Cheng B; Wang W; Lu B; Liu P; Lu W; Lu Y
Mol Cancer; 2019 Apr; 18(1):76. PubMed ID: 30940131
[TBL] [Abstract][Full Text] [Related]
14. Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.
Li B; Hu Y; Ye F; Li Y; Lv W; Xie X
Int J Gynecol Cancer; 2010 May; 20(4):597-604. PubMed ID: 20442590
[TBL] [Abstract][Full Text] [Related]
15. CPE overexpression is correlated with pelvic lymph node metastasis and poor prognosis in patients with early-stage cervical cancer.
Shen HW; Tan JF; Shang JH; Hou MZ; Liu J; He L; Yao SZ; He SY
Arch Gynecol Obstet; 2016 Aug; 294(2):333-42. PubMed ID: 26695643
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
17. Serum miR-3142 could be Used as a Potential Biomarker to Screen Cervical Cancer Patients from Healthy Controls.
Luo Q; Wang H; Li J
Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969093
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.
Yang Y; Song KL; Chang H; Chen L
Diagn Pathol; 2014 Dec; 9():220. PubMed ID: 25551621
[TBL] [Abstract][Full Text] [Related]
19. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
20. Prognostic utility of serum YKL-40 in patients with cervical cancer.
Roslind A; Palle C; Johansen JS; Christensen IJ; Nielsen HJ; Mosgaard BJ
Scand J Clin Lab Invest; 2020 Dec; 80(8):687-693. PubMed ID: 33186077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
